Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jul;74(7):4149-56.
doi: 10.1128/IAI.00150-06.

A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1

Affiliations

A monoclonal antibody to Bacillus anthracis protective antigen defines a neutralizing epitope in domain 1

Johanna Rivera et al. Infect Immun. 2006 Jul.

Abstract

Antibody (Ab) responses to Bacillus anthracis toxins are protective, but relatively few protective monoclonal antibodies (MAbs) have been reported. Protective antigen (PA) is essential for the action of B. anthracis lethal toxin (LeTx) and edema toxin. In this study, we generated two MAbs to PA, MAbs 7.5G and 10F4. These MAbs did not compete for binding to PA, consistent with specificities for different epitopes. The MAbs were tested for their ability to protect a monolayer of cultured macrophages against toxin-mediated cytotoxicity. MAb 7.5G, the most-neutralizing MAb, bound to domain 1 of PA and reduced LeTx toxicity in BALB/c mice. Remarkably, MAb 7.5G provided protection without blocking the binding of PA or lethal factor or the formation of the PA heptamer complex. However, MAb 7.5G slowed the proteolytic digestion of PA by furin in vitro, suggesting a potential mechanism for Ab-mediated protection. These observations indicate that some Abs to domain 1 can contribute to host protection.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
(A) Inverse Ab titers of BALB/c mice immunized with PA83 protein. Mice were immunized with 2 μg (C mice) or 10 μg (D mice) of PA83 protein. Mouse D3 was chosen for hybridoma generation using standard hybridoma technology. (Naïve mice, no responses.) (B) Analysis of cellular toxicity in the presence of PA83 MAbs by the MTT assay. MAbs 7.5G and 10F4 can protect MSH alveolar and J774 macrophage monolayers against LeTx-mediated toxicity as compared to medium alone and LeTx alone. Bars denote the average results for four wells, and error bars (too small to be visible) denote standard deviations. (C) Lung function as measured by WBP in mice treated with MAb before administration of LeTx. MAbs 7.5G and PBS were administered intraperitoneally 24 h prior to LeTx injection. Bars denote the average results for three mice, and error bars indicate standard deviations. TV, tidal volume; Ti, inspiratory time; Te, expiratory time; PIF, peak inspiratory flow; PEF, peak expiratory flow; *, P <0.05.
FIG. 2.
FIG. 2.
(A) Analysis of Ab binding to PA63 and PA83 by ELISA. MOPC21 IgG1 was used as a negative control for the ELISA. Insert, schematic of ELISA. GAM-AP, alkaline phosphatase-labeled goat anti-mouse Ab reagent. (B) Analysis of Ab binding to expressed PA domains (12.05 μM). MAb 7.5G (upper panel) bound to all expressed domains: (i) domains 1 and 2 (1-2); (ii) domains 1, 2, and 3 (1-3); (iii) domains 1, 2, 3, and 4 (1-4); and (iv) domain 1. MAb 10F4 (lower panel) bound primarily to domains 1 to 4 with minimal binding to domains 1and 2 and 1 to 3. ELISAs were done twice with similar results. PA83 was used as a positive control. OD405, optical density at 405 nm. (C) SDS-PAGE analysis of MAb 7.5G epitope mapping. MW, molecular weight markers (in kDa); lane 1, PA83; lane 2, PA83 digested with trypsin; lane 3, PA83 digested with furin; lane 4, PA83 digested with trypsin plus MAb 7.5G; lane 5, PA83 digested with furin plus MAb 7.5G; lane 6, PA83 digested with trypsin plus MOPC21; lane 7, PA83 digested with furin plus MOPC21.
FIG. 3.
FIG. 3.
(A) Binding of 188Re-PA83 to J774 macrophages at 4°C in the absence and presence of MAb 7.5G. Molar ratios of PA83: MAb were 1:1 and 1:50. (B) Binding of 188Re-PA83 and LF to macrophages in the absence and presence of MAb 7.5G. (C) Binding of 188Re-PA83 to J774 macrophages with blocked Fc receptors. These experiments were done for 15 and 60 min at 4°C with similar results. (D) PA63 oligomer formation in the presence and absence of MAb 7.5G. Lane 1, PA63; lane 2, PA63 with MAb 7.5G.
FIG. 4.
FIG. 4.
(A) Cleavage of PA83 with furin in the absence and presence of MAb 7.5G over several time intervals. MW, molecular weight markers (in kilodaltons); lanes 1, 3, 5, 7, 9, and 11, PA83 with furin; lanes 2, 4, 6, 8, 10, and 12, PA83 with furin plus MAb; lane 13, undigested PA83. Aliquots of PA83 were removed at 30-s and 1-, 2-, 3-, 4-, and 5-min time intervals for SDS-PAGE analysis. (B) ImageQuant analysis of bands. Key in 30-s graph applies to all panels.

Similar articles

Cited by

References

    1. Blaustein, R. O., T. M. Koehler, R. J. Collier, and A. Finkelstein. 1989. Anthrax toxin: channel-forming activity of protective antigen in planar phospholipid bilayers. Proc. Natl. Acad. Sci. USA 86:2209-2213. - PMC - PubMed
    1. Brossier, F., M. Lévy, A. Landier, P. Lafaye, and M. Mock. 2004. Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies. Infect. Immun. 72:6313-6317. - PMC - PubMed
    1. Casadevall, A., J. Mukherjee, and M. D. Scharff. 1992. Monoclonal antibody based ELISAs for cryptococcal polysaccharide. J. Immunol. Methods 154:27-35. - PubMed
    1. Collier, R. J., and J. A. Young. 2003. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19:45-70. - PubMed
    1. Culley, N. C., D. M. Pinson, A. Chakrabarty, M. S. Mayo, and S. M. LeVine. 2005. Pathophysiological manifestations in mice exposed to anthrax lethal toxin. Infect. Immun. 73:7006-7010. - PMC - PubMed

Publication types

LinkOut - more resources